BridgeBio raises $1 billion in convertible preferred equity

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. FLG
4. GMAB
5. ACCV
6. QQQ
7. TSLA
8. SPCX
9. XNCR
10. AZN

Go back to BridgeBio raises $1 billion in convertible preferred equity

BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches

July 1, 2026 7:30 AM EDT

- Preferred equity investment led by Sixth Street and with participation from HealthCare Royalty, a business of KKR, with an initial conversion price of approximately $138 per share (more than 100% premium to Companys 30-day VWAP)

- The financing significantly strengthens the Companys balance sheet, enabling it to efficiently allocate capital across its highest return opportunities

- The financing comes at a pivotal moment for the Company, as Attruby® continues to grow into a multi-billion-dollar blockbuster drug, and as BridgeBio prepares for three additional potential blockbuster U.S. product launches over the next 12 months across... More